Introduction
Primary palmar hyperhidrosis (PPH) is a chronic disorder characterized by excessive sweating of the palms, typically presenting in adolescence or early adulthood. Individuals affected by this condition face considerable challenges in their social and professional lives. Persistence of symptoms may lead to a loss of self-confidence, social isolation, and occupational limitations, all of which have a significant impact on the quality of life. The prevalence of PPH in the general population is estimated at 1%–3%, with higher rates observed in younger and more physically active groups.1
Although the exact cause of PPH is not fully understood, it has been associated with hyperactivity of the sympathetic nervous system. Treatment options can be divided into nonsurgical and surgical. Nonsurgical treatments include topical antiperspirants, botulinum toxin injections, and iontophoresis. While these methods provide temporary relief, especially in mild-to-moderate cases, they are often not a long-term solution, as they require repeated use.2
On the other hand, surgical treatments offer permanent solutions for PPH. Procedures such as sympathicotomy and sympathectomy target the sympathetic chain, and are known for their long-term effectiveness. During sympathectomy, a portion of the nerve chain is permanently removed, while sympathicotomy involves severing the chain without its removal. In recent years, uniportal video-assisted thoracoscopic surgery (U-VATS) has become increasingly accepted as a minimally invasive surgical method for sympathicotomy. However, there are limited literature data on the optimal level of sympathetic chain interruption (isolated T3 sympathicotomy or combined T3–T4 sympathicotomy) and the influence of patient sex on surgical outcomes.3,4
Existing studies have generally compared the efficacy and complications of isolated T3 and combined T3–T4 sympathicotomy; however, the impact of sex differences on surgical outcomes has not been adequately investigated. This gap represents a significant limitation in surgical planning and patient counseling.5
Aim
The aim of this study was to evaluate and compare the efficacy, complication rates, and prevalence of symptom relief of isolated T3 and combined T3–T4 sympathicotomy. In addition, the impact of sex on surgical outcomes was investigated. By providing evidence-based insights into the comparative safety and efficacy of these procedures, this study aimed to help clinicians select the optimal surgical approach, particularly taking into account sex-specific risk factors and long-term outcomes.
Materials and methods
Patients
This was a retrospective analysis of 327 patients with PPH who underwent a single-session bilateral U-VATS sympathicotomy at our hospital between November 2012 and May 2022. The patients were divided into 2 groups: those undergoing isolated T3 sympathicotomy (n = 167; group 1) and those undergoing combined T3–T4 sympathicotomy (n = 160; group 2). We collected data on patient demographics as well as the rates of treatment success, complete symptom resolution, recurrence, and complications. The data were extracted from hospital records, surgical reports, outpatient follow-up reports, and discharge notes.
Patients aged 18 to 50 years, with a clinical diagnosis of PPH confirmed by medical history and physical examination were included (Figure 1). Exclusion criteria comprised previous thoracic surgery, significant comorbidities (eg, severe cardiovascular or pulmonary disease), and secondary hyperhidrosis due to a systemic or metabolic disease.

Figure 1. Image showing palmar hyperhidrosis
Surgical procedure
All patients were placed in the semi-Fowler position, with arms bent at 90 degrees, and intubated with a double-lumen endobronchial tube. Sympathicotomy was performed bilaterally during the same session through a 5-mm incision in the third intercostal space, along the midaxillary line. It involved careful dissection and transection of the sympathetic chain, and electrocautery ablation of the Kuntz nerves. There were no technical differences between the T3 and T3–T4 procedures (Figure 2).

Figure 2. Images showing uniportal video-assisted thoracoscopic sympathicotomy (intraoperative view and positioning of the instruments)
Postoperatively, the intrathoracic air was aspirated with a 12-F chest catheter. There were no intraoperative complications, and all patients recovered quickly without the need for intensive medical care. No patient required placement of a chest drain or prolonged hospitalization due to serious postoperative complications.
Statistical analysis
Categorical variables were presented as frequencies and percentages, while continuous variables were expressed as means with SD (for normally distributed data) or medians with interquartile ranges (for non-normally distributed data). The Levene test was used to assess homogeneity between the groups. The χ2 test was used to analyze categorical data, including a comparison of the overall complication rates between the groups, while the t test or Mann–Whitney test was used to compare continuous variables, depending on the normality of distribution. Logistic regression analysis was performed to assess the independent effects of age, sex, and duration of surgery on the complication rates. Odds ratios (ORs) with 95% CIs were reported for each predictor.
The effect size was measured using the Cohen d, which classifies the effect size as small (<0.2), medium (~0.5), or large (>0.8). Significance was defined as a P value below 0.05. All analyses were performed using the SPSS software, version 25.0 (IBM Corp., Armonk, New York, United States).
Ethical approval
This study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of the Istanbul Training and Research Hospital (1678). Informed consent was obtained from all patients prior to their inclusion in the study. Patient confidentiality was strictly maintained throughout the study and all identifying information was anonymized during data analysis.
Results
In this retrospective study, we analyzed 167 patients who underwent isolated T3 sympathicotomy (group 1) and 160 patients who underwent combined T3–T4 sympathicotomy (group 2). Demographic data, treatment success rates, rates of complete symptom resolution, as well as recurrence and complication rates were compared between the groups.
The group 1 comprised 98 men (58.7%) and 69 women (41.3%) at a mean (SD) age of 28.6 (6.2) years. In the group 2, there were 94 men (58.8%) and 66 women (41.2%), and the mean (SD) age was 29.1 (6) years. No differences were found between the groups in terms of age or sex distribution (Table 1).

Parameter | T3 sympathicotomy (n = 167) | T3–T4 sympathicotomy (n = 160) | P value | |
|---|---|---|---|---|
Age, y, mean (SD) | 28.6 (6.2) | 29.1 (6) | 0.67 | |
Sex | Men | 98 (58.7) | 94 (58.8) | 0.82 |
Women | 69 (41.3) | 66 (41.2) | ||
Duration of surgery, min, mean (SD) | 15 (4) | 20 (5) | 0.05 | |
Duration of hospitalization, d | 1 (1–1) | 1 (1–1) | 0.08 | |
Treatment success | 160 (95.8) | 150 (93.8) | 0.23 | |
Complete relief of symptoms | 155 (92.8) | 146 (91.3) | 0.18 | |
Symptom recurrence | 5 (3.0) | 7 (4.4) | 0.31 | |
Complications | 16 (9.6) | 23 (14.4) | 0.04 | |
Data are presented as number (percentage) or median (interquartile range) unless otherwise indicated. P values <0.05 were considered significant. | ||||
The mean (SD) duration of the procedure was 20 (5) minutes in the group 1 and 22 (6) minutes in the group 2 (Cohen d = 0.35; P = 0.05). The duration of hospitalization was similar in both groups, with a maximum length of stay of 1 day (P = 0.08).
The treatment success rate was 95.8% in the group 1 and 93.8% in the group 2 (Cohen d = 0.13; P = 0.23). Complete resolution of symptoms was achieved in 92.8% of the patients in the group 1 and 91.3% in the group 2 (Cohen d = 0.15; P = 0.18). These results show that both approaches are highly effective but isolated T3 sympathicotomy has slightly higher success and symptom resolution rates.
The postoperative recurrence rates were similar in the groups (3% in the group 1 vs 4.4% in the group 2; Cohen d = 0.11; P = 0.31), suggesting that the methods are comparable with respect to long-term results.
The observed complications included compensatory sweating, pneumothorax, hemothorax, skin infections, chest pain, dryness of the hands, and numbness in the fingers. The most common complication in both groups was hand dryness, with a prevalence of 4.5% in the group 1 and 6% in the group 2 (Cohen d = 0.08; P = 0.02). Compensatory sweating was observed in 2.5% of the patients in the group 1 and 3% of the patients in the group 2 (Cohen d = 0.09; P = 0.52).
The overall complication rate was lower in the group 1 than in the group 2 (9.85% vs 14.1%; Cohen d = 0.35; P = 0.04), suggesting that isolated T3 sympathicotomy is clinically safer (Table 2).

Complication | T3 sympathicotomy (n = 167) | T3–T4 sympathicotomy (n = 160) | P value | Men (n = 192) | Women (n = 135) | P value |
|---|---|---|---|---|---|---|
Compensatory sweating | 4 (2.4) | 5 (3.1) | 0.52 | 7 (3.65) | 2 (1.48) | 0.03 |
Pneumothorax | 1 (0.6) | 2 (1.25) | 0.6 |
| 1 (0.74) | 0.04 |
Hemothorax | 1 (0.6) | 1 (0.63) | 0.85 | 1 (0.52) | 1 (0.74) | 0.04 |
Skin infection | 1 (0.6) | 2 (1.25) | 0.5 | 1 (0.52) | 1 (0.74) | 0.05 |
Chest pain | 3 (1.8) | 4 (2.5) | 0.6 | 6 (3.12) | 2 (1.48) | 0.03 |
Hand dryness | 7 (4.2) | 10 (6.25) | 0.04 | 12 (6.25) | 5 (3.7) | 0.02 |
Finger numbness | 2 (1.2) | 2 (1.25) | 0.68 | 4 (2.8) | 2 (1.48) | 0.03 |
Data are presented as number (percentage) of patients. P values <0.05 were considered significant. | ||||||
The overall complication rate was significantly higher in men. In particular, compensatory sweating (Cohen d = 0.4), chest pain (Cohen d = 0.35), and hand dryness (Cohen d = 0.38) were more frequent and more severe in the male cohort (Figure 3). This can be attributed to a higher activity of the sympathetic nervous system in men.

Figure 3. Distribution of complication following T3 and T3–T4 sympathicotomy procedures by sex. The error bars indicate the standard error for each rate.
Multivariable logistic regression analysis examined the combined effects of age, sex, and duration of surgery on the likelihood of complication occurrence. None of these variables was identified as a significant predictor of complications. The ORs were 1.004 (95% CI, 0.951–1.061) for age, 0.986 (95% CI, 0.504–1.931) for sex, and 0.996 (95% CI, 0.936–1.061) for duration of surgery (Table 3).

Parameter | β coefficient | OR | 95% CI | P value |
|---|---|---|---|---|
Age | 0.004 | 1.004 | 0.951–1.061 | 0.88 |
Sex | –0.014 | 0.986 | 0.504–1.931 | 0.97 |
Duration of surgery | –0.004 | 0.996 | 0.936–1.061 | 0.91 |
Abbreviations: OR, odds ratio | ||||
Discussion
Primary hyperhidrosis affects about 0.6%–1% of the population and is often characterized by excessive sweating of the hands. Thoracic sympathectomy was first introduced in the 1930s, with Kux presenting significant advances in this technique in 1954.5 Since then, sympathectomy and sympathicotomy have become standard treatment methods for this condition. With the introduction of VATS in the 1990s, thoracic surgery evolved toward minimally invasive techniques.6 Among these, sympathicotomy is a faster and equally effective alternative to sympathectomy, with a similar safety profile.7,8
Despite its effectiveness, compensatory sweating remains a common and problematic side effect of sympathicotomy, with a reported incidence of 3%–98%, depending on the patient group and surgical approach.2 Other complications, such as Horner syndrome, recurrence, bleeding, and pneumothorax, are less common and occur in around 3%–10% of cases.9 The average duration of surgery reported in the literature is 30–60 minutes, whereas in our study, it was significantly shorter, at 20 minutes (range, 15–30 minutes).10,11 This difference could be due to procedural refinements and the use of a single-port technique, which has been shown to reduce the complexity of the procedure and recovery time.
Thoracic sympathectomy is widely regarded as a safe and effective treatment for PPH, providing relief in 90%–100% of patients. However, relapse occurs in up to 10% of cases, possibly due to anatomical variants, such as the Kuntz nerve or rami communicantes. Treating these branches near the T2, T3, and T4 ganglia can reduce the recurrence rate. However, procedures involving the T2 ganglion carry a significantly higher risk of compensatory sweating and, therefore, are less beneficial.12 The Society of Thoracic Surgeons recommends T3 or T4 sympathectomy for PPH, and points out that procedures performed at the T4 level carry a lower risk of compensatory sweating, but can lead to increased sweating of the palm. T4 or T5 incisions are often recommended for patients with combined hand and foot sweating.13
Our study is consistent with certain aspects of the previous research, but also points to contextual differences. Zhang et al14 reported that isolated T4 sympathicotomy reduced the rates of compensatory sweating, hand dryness, and gustatory sweating, relative to isolated T3 procedures. In contrast, our results showed that isolated T3 sympathicotomy had a lower overall complication rate than combined T3–T4 sympathicotomy without compromising efficacy. Xie et al15 observed lower rates of compensatory sweating after isolated T4 sympathicotomy, whereas our analysis of combined T3–T4 procedures revealed higher complication rates, especially for compensatory sweating and dryness of the hands. These apparent discrepancies may be due to differences in surgical focus (isolated vs combined procedures), patient demographics, or surgical techniques. For example, Zhang et al14 compared only isolated T3 and T4 procedures, whereas our study also focused on combined T3–T4 procedures, which may be associated with greater risks. This distinction emphasizes the importance of tailoring the surgical approach to the specific patient profile and anatomic conditions.
Yang et al16 found that combined T3–T4 sympathicotomy for plantar hyperhidrosis achieved higher success rates but, at the same time, resulted in higher complication rates, as compared with isolated T3 sympathicotomy. Our study did not focus on plantar hyperhidrosis; however, we found that isolated T3 sympathicotomy was sufficient to achieve symptom relief in palmar hyperhidrosis cases, highlighting the importance of minimizing unnecessary surgical risks. Huang et al17 also reported a reduction in compensatory sweating and dryness of the hands with T4 procedures, but noted increased palm moisture—a finding consistent with our observations of higher complication rates for the procedures involving resection at the T4 level.
A major strength of our study is the identification of sex-specific differences in surgical outcomes. We noted significantly higher rates of complications among men, including compensatory sweating, chest pain, and hand dryness. This observation supports the hypothesis that men may have increased sympathetic nervous system activity, as proposed in previous studies.18 In addition, Sang et al19 suggested that avoidance of T2 sympathicotomy may reduce the risk of compensatory sweating and Horner syndrome, which is consistent with our findings that isolated T3 sympathicotomy has a more favorable safety profile. Similarly, Dogru et al20 found that while T2–T4 sympathicotomies can improve quality of life, isolated T3 sympathicotomy results in fewer complications. These findings underscore the importance of individualizing the surgical approach, incorporating sex-specific considerations, and focusing on choosing optimal levels of intervention to improve patient-related outcomes. They highlight the significant influence of sex on the risk of complications, which should be carefully considered in clinical decision-making. This study emphasizes the important role of sex in determining postoperative outcomes of U-VATS sympathicotomy for PPH. We found that postoperative complications, particularly compensatory sweating, chest pain, and dryness of the hands, are more common in men. These differences may be attributed to sex-specific differences in autonomic nervous system activity. Previous studies have reported that men tend to show a stronger sympathetic nervous system response than women, which could lead to more pronounced postoperative side effects. In addition, differences in skin structure, sweat gland distribution, and hormonal balance may contribute to the observed variability in surgical outcomes.21-23
It has been suggested that women are generally more satisfied with the outcomes of sympathicotomy, possibly due to a lower prevalence of severe compensatory sweating in female patient populations. Some researchers have hypothesized that estrogen-induced modulation of the sympathetic chain activity may have a protective effect against excessive postoperative reactions. In addition, anatomical differences, including variations in nerve branching patterns, could influence the effectiveness of the surgical procedure between the sexes.23
Tailored approaches, such as changes in the extent of sympathicotomy or the use of alternative techniques (eg, stapled sympathectomy), could help reduce the risk of complications in men.24 Future studies with larger sample sizes and longer follow-up periods are needed to further elucidate the role of sex in determining the long-term success and safety of sympathicotomy procedures.
Shorter operative time associated with T3 sympathicotomy not only increases patient safety, but also improves the efficiency of the procedure, making it a practical choice for high-volume centers and outpatient facilities. Given the higher predisposition to postoperative complications in men, tailored preoperative counseling and risk mitigation strategies are recommended for this patient group.
Furthermore, our results suggest that performing sympathectomy at the T4 level for palmar hyperhidrosis does not provide significant benefits, but increases the risk of complications. For patients with concomitant hand and foot hyperhidrosis, further investigation is needed to determine the optimal level of intervention that would minimize the risk of complications.
Although our study provides clear evidence of the safety and efficacy of T3 sympathicotomy, further research is warranted in several areas. Higher complication rates in men emphasize the need for studies to investigate the physiological or anatomical factors underlying these differences. In addition, long-term follow-up studies are needed to investigate recurrence rates, patient satisfaction, and improvement in quality of life. The inclusion of patient-reported outcomes in future studies could provide a more holistic perspective on successful treatment.
In addition, development of advanced surgical techniques or technological innovations, such as robotic thoracoscopy, could improve the precision and outcomes of these procedures. Research into preoperative assessments or imaging techniques that would help predict complications and optimize surgical planning could also prove valuable.
This study contributes to the growing body of knowledge on the optimal surgical treatment of PPH. In contrast to previous studies that emphasized the potential benefits of T4 sympathicotomy or combined T3–T4 procedures, our results show that similar or better results with fewer complications can be achieved with isolated T3 sympathicotomy. This study also highlights the importance of sex-specific considerations in surgical planning, filling a gap in the current literature.
Conclusions
Isolated T3 sympathicotomy is an effective and safe treatment option for PPH, with high success rates and fewer complications, as compared with combined T3–T4 procedures. Addition of T4 ganglion resection increases the risk of complications, such as dryness of the hands and compensatory sweating, with no clear efficacy benefit.
Higher complication rates in men emphasize the importance of considering sex-specific factors in surgical planning. Isolated T3 sympathicotomy should be the preferred approach for most patients, while further research is needed to investigate sex differences and long-term outcomes.
Turkan Dubus, MD, PhD, Department of Thoracic Surgery, Basaksehir Cam and Sakura City Hospital, Basaksehir Mahallesi G-434 Caddesi No. 2L, 34480 Basaksehir / Istanbul, Turkey, phone: +90 212 909 60 00 / 21888, email: drturkandbs@yahoo.com
January 17, 2025.
February 3, 2025.
February 10, 2025.
None.
None.
TD: conceptualization, formal analysis, investigation, methodology, project administration, writing – original draft preparation, writing – review & editing; GC: conceptualization, methodology; FK: conceptualization, methodology
Artificial intelligence was not used to write the article.
None declared.
Dubus T, Cangel G, Kesmezacar F. Influence of sex on the outcomes of uniportal video-assisted thoracoscopic sympathicotomy for primary palmar hyperhidrosis. Wideochir Inne Tech Maloinwazyjne. 2025; 20: 55-60. doi:10.20452/wiitm.2025.17934
- 1.
- Sternbach JM, DeCamp MM. Targeting the sympathetic chain for primary hyperhidrosis: an evidence-based review. Thorac Surg Clin. 2016; 26: 407-420.Crossref
- 2.
- Street E, Ashrafi M, Greaves N, Gouldsborough I. Anatomic variation of rami communicantes in the upper thoracic sympathetic chain: a human cadaveric study. Ann Vasc Surg. 2016; 34: 243-249.Crossref
- 3.
- Elalfy K, Emile S, Elfeki H, et al. Sequential extended thoracoscopic sympathicotomy for palmo-axillo-plantar hyperhidrosis. Ann Thorac Surg. 2017; 104: 1200-1207.Crossref
- 4.
- Kocher GJ, Taha A, Ahler M, Schmid RA. Is clipping the preferable technique to perform sympathicotomy? A retrospective study and review of the literature. Langenbecks Arch Surg. 2015; 400: 107-112.Crossref
- 5.
- Kux E. The endoscopic approach to the vegetative nervous system and its therapeutic possibilities; especially in duodenal ulcer, angina pectoris, hypertension and diabetes. Dis Chest. 1951; 20: 139-147.Crossref
- 6.
- Ong W, Lee A, Tan WB, Lomanto D. Long-term results of a randomized controlled trial of T2 versus T2-T3 ablation in endoscopic thoracic sympathectomy for palmar hyperhidrosis. Surg Endosc. 2016; 30: 1219-1225.Crossref
- 7.
- Chen S, Zhang P, Chai T, et al. T3 versus T4 video-assisted thoracoscopic sympathectomy for palmar hyperhidrosis: a protocol for a systematic review and meta-analysis. Medicine (Baltimore). 2019; 98: 17272.Crossref
- 8.
- Weng W, Li X, Pei G, et al. Anatomical variation of sympathetic ganglia in R4+R5 sympathicotomy for primary palmar axillary hyperhidrosis. J Thorac Dis. 2023; 15: 3106-3114.Crossref
- 9.
- Soares TJ, Dias PG, Sampaio SM. Impact of video-assisted thoracoscopic sympathectomy and related complications on quality of life according to the level of sympathectomy. Ann Vasc Surg. 2020; 63: 63-67.Crossref
- 10.
- Karamustafaoglu YA, Kuzucuoglu M, Yanik F, Sagiroglu G. 3-year follow-up after uniportal thoracoscopic sympathicotomy for hyperhidrosis: undesirable side effects. J Laparoendosc Adv Surg Tech A. 2014; 24: 782-785.Crossref
- 11.
- Musa AF, Gandhi VP, Dillon J, et al. A retrospective review on minimally invasive technique via endoscopic thoracic sympathectomy (ETS) in the treatment of severe primary hyperhidrosis: experiences from the National Heart Institute, Malaysia. F1000Res. 2018; 7: 670.Crossref
- 12.
- Jung HS, Lee DY, Park JS. Alternative surgical methods in patients with recurrent palmar hyperhidrosis and compensatory hyperhidrosis. Yonsei Med J. 2018; 59: 345-348.Crossref
- 13.
- Aydemir B, Imamoglu O, Okay T, Celik M. Sympathectomy versus sympathicotomy in palmar hyperhidrosis comparing T3 ablation. Thorac Cardiovasc Surg. 2015; 63: 715-719.Crossref
- 14.
- Zhang W, Wei Y, Jiang H, et al. T3 versus T4 thoracoscopic sympathectomy for palmar hyperhidrosis: a meta-analysis and systematic review. J Surg Res. 2017; 218: 124-131.Crossref
- 15.
- Xie H, Lu T, Zhu Y, et al. A retrospective cohort study of T3 versus T4 thoracoscopic sympathectomy for primary palmar hyperhidrosis and primary palmar hyperhidrosis with axillary and plantar sweating. Wideochir Inne Tech Maloinwazyjne. 2020; 15: 488-495.Crossref
- 16.
- Yang C, Li Z, Bai H, et al. Long-term efficacy of T3 versus T3+T4 thoracoscopic sympathectomy for concurrent palmar and plantar hyperhidrosis. J Surg Res. 2021; 263: 224-229.Crossref
- 17.
- Huang L, Jiang H, Wei D, et al. A comparative study of thoracoscopic sympathectomy for the treatment of hand sweating. J Thorac Dis. 2019; 11: 3336-3340.Crossref
- 18.
- Sang HW, Li GL, Xiong P, et al. Optimal targeting of sympathetic chain levels for treatment of palmar hyperhidrosis: an updated systematic review. Surg Endosc. 2017; 31: 4357-4369.Crossref
- 19.
- Dogru MV, Sezen CB, Girgin O, et al. Is there any relationship between quality of life and the level of sympathectomy in primary palmar hyperhidrosis? Single-center experience. Gen Thorac Cardiovasc Surg. 2020; 68: 273-279.Crossref
- 20.
- Vanaclocha V, Guijarro-Jorge R, Saiz-Sapena N, et al. Selective T3-T4 sympathicotomy versus gray ramicotomy on outcome and quality of life in hyperhidrosis patients: a randomized clinical trial. Sci Rep. 2021; 11: 17628.Crossref
- 21.
- Kuijpers M, Peeters G, Harms PW, et al. Bilateral one-stage single-port sympathicotomy in primary focal hyperhidrosis, a prospective cohort study: treat earlier? J Cardiothorac Surg. 2021;16: 50.Crossref
- 22.
- Hirakawa N, Higashimoto I, Takamori A, et al. The impact of endoscopic thoracic sympathectomy on sudomotor function in patients with palmar hyperhidrosis. Clin Auton Res. 2021; 31: 225-230.Crossref
- 23.
- Martínez-Hernández NJ, Estors-Guerrero M, Galbis-Caravajal JM, et al. Endoscopic thoracic sympathectomy for primary hyperhidrosis: an over a decade-long follow-up on efficacy, impact, and patient satisfaction. J Thorac Dis. 2024; 16: 8292-8299.Crossref
- 24.
- Kobayashi M, Kumaya Y, Hirayama Y, et al. Single-center experience of thoracoscopic sympathectomy for palmar hyperhidrosis with long-term postoperative questionnaire survey. Gen Thorac Cardiovasc Surg. 2024; 72: 732-737.Crossref